Status:
COMPLETED
A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.
Lead Sponsor:
Bayer
Conditions:
Erectile Dysfunction
Eligibility:
MALE
18-64 years
Phase:
PHASE4
Brief Summary
The objective of this study was to evaluate the efficacy and tolerability of the phosphodiesterase type 5 inhibitor (PDE5 inhibitor), vardenafil, in a broad population of subjects with erectile dysfun...
Eligibility Criteria
Inclusion
- Males with erectile dysfunction according to the National Institute of Health (NIH) Consensus statement (inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance
- Heterosexual relationship for more than 6 months
- Partner willing to complete the TSS
Exclusion
- Primary hypoactive sexual desire
- History of myocardial infarction, stroke or life-threatening arrhythmia within the prior 6 months
- Nitrate use
- Other exclusion criteria apply according to the Summary of Product Characteristics
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2005
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT00668096
Start Date
May 1 2004
End Date
January 1 2005
Last Update
December 25 2014
Active Locations (38)
Enter a location and click search to find clinical trials sorted by distance.
1
Bruxelles - Brussel, Belgium, 1000
2
Drieslinter, Belgium, 3350
3
Genk, Belgium, 3600
4
Leuven, Belgium, 3000